Imugene Limited (IUGNF)

Imugene Income Statement

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Other Revenue	4.4	4.97	11.78	12.97	7.23
Revenue	4.4	4.97	11.78	12.97	7.23
Revenue Growth (YoY)	-11.53%	-57.80%	-9.19%	79.35%	74.94%
Gross Profit	4.4	4.97	11.78	12.97	7.23
Selling, General & Admin	27.77	59.91	20.43	14.06	10.31
Research & Development	46.69	86.89	30.86	36.61	15.36
Operating Expenses	74.46	146.79	51.29	50.67	25.67
Operating Income	-70.06	-141.82	-39.52	-37.7	-18.43
Interest Expense	-0.16	-0.48	-0.03	-0.01	-0.01
Interest & Investment Income	2.08	4.52	1.88	0.19	0.13
Currency Exchange Gain (Loss)	-0.67	-0.63	-0.25	-0.13	-0.08
Other Non Operating Income (Expenses)	-	-	-	-0.11	-0.11
EBT Excluding Unusual Items	-68.81	-138.42	-37.91	-37.76	-18.51
Gain (Loss) on Sale of Assets	-0.21	-11.26	-0	-0.1	-
Other Unusual Items	-	-	-	-	0.05
Pretax Income	-69.02	-149.68	-37.91	-37.87	-18.46
Net Income	-69.02	-149.68	-37.91	-37.87	-18.46
Net Income to Common	-69.02	-149.68	-37.91	-37.87	-18.46
Shares Outstanding (Basic)	219	208	185	166	137
Shares Outstanding (Diluted)	219	208	185	166	137
Shares Change (YoY)	4.90%	12.96%	11.33%	20.88%	14.45%
EPS (Basic)	-0.32	-0.72	-0.21	-0.23	-0.13
EPS (Diluted)	-0.32	-0.72	-0.21	-0.23	-0.13
Free Cash Flow	-83.12	-108.8	-31.47	-31.11	-13.42
Free Cash Flow Per Share	-0.38	-0.52	-0.17	-0.19	-0.10
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	-1593.52%	-2853.55%	-335.51%	-290.70%	-254.92%
Profit Margin	-1569.81%	-3011.66%	-321.92%	-291.98%	-255.21%
Free Cash Flow Margin	-1890.42%	-2189.12%	-267.21%	-239.83%	-185.53%
EBITDA	-67.42	-137.45	-37.31	-35.45	-16.55
EBITDA Margin	-	-	-	-273.30%	-228.81%
D&A For EBITDA	2.64	4.38	2.2	2.26	1.89
EBIT	-70.06	-141.82	-39.52	-37.7	-18.43
EBIT Margin	-	-	-	-290.70%	-254.92%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.